Stroke occurrence while on antiplatelet therapy may predict atrial fibrillation detected after stroke

Stroke occurrence while on antiplatelet therapy, i.e., a breakthrough stroke, is often conveniently attributed to antiplatelet resistance. However, undetected paroxysmal atrial fibrillation (AF) may underlie breakthrough strokes. We hypothesized that a breakthrough stroke may be a clinical marker for patients at risk of having AF detected after stroke (AFDAS).
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research